Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(45.5%)

Phase 2

4(36.4%)

Phase 1

2(18.2%)

11Total

N/A(5)

Phase 2(4)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT04276740Phase 2Active Not Recruiting

MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis

Role: collaborator

NCT05080556Phase 2Recruiting

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

Role: collaborator

NCT03795506Not ApplicableUnknown

TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)

Role: collaborator

NCT03967106Not ApplicableCompleted

RIPC on Activity, Fatigue and Gait in MS

Role: collaborator

NCT02216175Not ApplicableCompleted

Improving the Safety of Oral Immunotherapy for Cow's Milk Allergy

Role: collaborator

NCT04913025Phase 2Unknown

REduced Frequency ImmuNE Checkpoint Inhibition in Cancers

Role: collaborator

NCT03840005Phase 2Completed

Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study

Role: collaborator

NCT03875937Phase 1Completed

The Trauma INtramuscular Tranexamic Acid Clinical Trial

Role: collaborator

NCT01826890Not ApplicableCompleted

Neurally Adjusted Ventilatory Assist in Adults at Risk of Delayed Weaning From Mechanical Ventilation

Role: collaborator

NCT01195480Phase 1Terminated

CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)

Role: collaborator

NCT00977366Not ApplicableCompleted

Neurophysiology of Cough Reflex Hypersensitivity

Role: collaborator

All 11 trials loaded